Lita Equity investment Financé

Ce projet est clôturé. L'analyse ci-dessous reflète les informations disponibles au moment de la souscription et n'a pas été mise à jour.

Ecoxtract – 1001PACT Ecoxtract Holding

Fragile

score / 100

Min. ticket

300 €

Amount raised

438 k€

Invest →

À propos

Investment in ordinary shares of Ecoxtract, deeptech startup created in 2023 in Dunkirk, developing Ecomeo, a biobased solvent alternative to hexane for extraction of oils and food proteins. Company is pre-revenue (TRL 6), with European regulatory approvals obtained. Fundraising conducted via SPV holding (1001PACT Ecoxtract) on the Lita platform, licensed AMF PSFP. Profitability targeted from 2029 according to business plan.

Plateforme · 18.0/25

A1 · Statut réglementaire 8.0/8✓ max

AMF agrément AMF n°fonds propres-2023-27 confirmed in société dédiée (SPV) and FICI articles
Licence in force

A2 · Track Record 2.0/6faible

Score adjusted via live data: default 7.05% (→1.5pts×0.5=0.75), delay 17.91% (→3pts×0.3=0.9), equity return N/C (→0pts×0.2=0)
Opacity penalty not applied as figures published

A3 · Rigueur de sélection 3.0/4bon

Detailed process 1.5-4 months, impact and financial analysis, site visits, stakeholders
Selection rate not published

A4 · Santé financière 3.0/4bon

Independent platform >5 years, capital 40,465€ modest, impact investors (Phitrust, Aviva), no distress signal
Capsens continuity documented

A5 · Protection investisseurs 2.0/3

4-day reflection period documented FICI (agrément AMF mandatory)
Capsens continuity = documented plan
Segregated accounts not explicitly detailed
No secondary market

Projet · 23.0/75

B1 · Instrument & Structure 4.0/10faible

B1.1: 1/5 - Ordinary shares, equity instrument, subordinated, total loss possible

B1.2: 3/3 - Dedicated société dédiée (SPV) 1001PACT Ecoxtract, clear French law

B1.3: 0/2 - Explicitly subordinated to all creditors, no priority rank

B2 · Opérateur & Track record 9.0/15

B2.1: 4/4 - Laurence Jacques appointed, Polytechnique graduate, verifiable LinkedIn profile

B2.2: 2/5 - Startup <3 years, senior team 25+ years relevant chemical industry experience

B2.3: 1/3 - First Lita operation, verifiable reputation elsewhere

B2.4: 2/3 - EY auditor, 2025 accounts certified, no proceedings identified; gearing not calculable pre-revenue startup

B3 · Garanties & Sûretés 0.0/15faible

B3.1: 0/9 - Pure equity instrument, no real guarantees structurally possible

B3.2: 0/4 - No guarantor identified

B3.3: 0/2 - No banking partner (<€2M project, RF2 not triggered)

B4 · Structure financière 2.0/15faible

B4.1: 0/5 - taux de couverture de la dette <1.0, pre-revenue company, negative EBITDA through 2028

B4.2: 2/4 - Capital 3.877M€ raised, 5M€ injection planned 2026, founder commitment real

B4.3: 0/4 - No stress test, negative EBITDA through 2028 with no margin

B4.4: 0/2 - Negative EBITDA over entire 2025-2028 period

B5 · Pré-commercialisation 3.0/10faible

Lab collaborations documented (Synarome, Givaudan, Exinnov)
Named pipeline 2028-2030 (AAK, Ingredion)
Early traction real
No firm contracts, 2025 revenue symbolic (22,764€)

B6 · Permis & Maturité 3.0/5

EFSA approval 2022/2023 obtained (Directive 2009/32/CE)
TRL 6 proven
EY auditor, sound legal structure
Activity <3 years, startup early commercial phase

B7 · Marché & Localisation 2.0/3

Solid TAM market €6.4Bn→€8.6Bn 2030
Strong regulatory tailwind (hexane SVHC 2026)
First-mover with 4 patent families
Execution and industrial adoption risk remain significant

Points forts

✓Founding team senior with 25+ years relevant industrial experience (chemistry, extraction)

✓EFSA regulatory approval obtained and favourable regulatory tailwind (hexane SVHC 2026)

✓TRL 6 proven, patented technology (4 families), high additionality with no viable competitor

✓Early commercial traction documented with recognised players (Synarome, Givaudan)

✓Lita platform AMF PSFP licensed, dedicated SPV with clear legal structure

Risques identifiés

!Nature of operation: capital investment (shares), not a loan. The displayed score was calculated using the debt grid, which scores under B3 real guarantees that a capital investment does not have by construction. This score is therefore structurally penalising and under review with the capital grid (contractual protections, valuation, dilution, exit mechanism).

!Pure equity instrument: total loss risk, no guarantees, no dividend forecast before 2029

!Pre-revenue company with negative EBITDA through 2028; total dependence on future fundraisings

!Lita default rate 7.05% and delay rate 17.91% high for an equity impact platform

!Zero liquidity: unlisted shares, uncertain exit horizon (full sale targeted post-2030)

!Uncertain industrial adoption: 2028-2030 customer named but no firm contract at this stage

⚠ Avertissement sur les risques

Investir en crowdfunding comporte un risque de perte partielle ou totale du capital, ainsi qu'un risque d'illiquidité. Selon le baromètre France FinTech / Forvis Mazars 2025, 25 à 30 % des projets accusent un retard de plus de 6 mois et 4 à 6 % entraînent une perte définitive. Ne placez jamais plus de 5 à 10 % de votre patrimoine en crowdfunding et diversifiez sur au moins 10 projets. CrowdPickr est un service d'information indépendant, non agréé en tant que conseiller en investissement. Les analyses présentées ne constituent pas un conseil en investissement personnalisé.